Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 5Pain 3Cachexia 3Breast Neoplasms 3Trigger Finger Disorder 2Prostatic Neoplasms 2Lymphoma, Follicular 2Lung Neoplasms 2Inflammation 2Ganglion Cysts 2De Quervain Disease 2Colorectal Neoplasms 2Weight Loss 1Uveal Melanoma 1Uterine Cervical Neoplasms 1Supratentorial Brain Tumor 1Stomach Neoplasms 1Rectal Neoplasms 1Prostatitis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pleural Effusion, Malignant 1Pituitary Neoplasms 1Patient Satisfaction 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Nose Neoplasms 1Neoplasm Metastasis 1Mucositis 1Menorrhagia 1

Interventions

Exercise 6Transcranial Direct Current Stimulation 4Neuropsychological Tests 4Walking 3Memantine 3Tablets 2Standard of Care 2Patient Reported Outcome Measures 2Methods 2Electroencephalography 2Drug Therapy 2Donepezil 2Cognitive Behavioral Therapy 2mazdutide 1lithium sulfate 1lime 1fasudil 1enzalutamide 1blueberry extract 1beta Carotene 1acetaminophen, aspirin, caffeine drug combination 1XENP 1595 1Vitamin E 1Vitamin D 1Ultraviolet Therapy 1Transcranial Magnetic Stimulation 1Time 1Therapeutics 1Tai Ji 1Surveys and Questionnaires 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cognitive Dysfunction × Ibuprofen × Clear all
NCT03186638 2023-09-25

Low-Dose Ibuprofen in Improving Cognitive Impairment in Patients With Cancer

University of Rochester

Phase 2 Completed
87 enrolled 13 charts

Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡